Current Research in Microbial Sciences
Current Research in Microbial Sciences is a gold open access journal published by Elsevier, launched in September 2020 as the companion of Current Opinion in Microbiology within the Current Opinion and Research suite and covering all aspects of microbiology, with a 2025 Journal Impact Factor of 5.6.《微生物科学最新研究》(Current Research in Microbial Sciences)由(Elsevier)出版,2020 年 9 月创刊,是(Current Opinion and Research)期刊群中(Current Opinion in Microbiology)的原创研究姊妹刊,覆盖微生物学各个方面,2025 年期刊影响因子为 5.6。
Scope
- The journal publishes original papers, short communications, review articles and graphical reviews covering all aspects of microbiology, the study of microorganisms and their biological interactions with human beings and other life.本刊刊载原创论文、短篇通讯、综述与图解综述,覆盖微生物学各个方面,即微生物及其与人类和其他生命形式生物学相互作用的研究。
- Listed topics run from genetics and the metabolism of bacteria, fungi, protozoa and viruses to environmental microbiology, host-microbe interactions, antimicrobials, microbial systems biology, biofilms and microbiota.官方列举的主题自遗传学及细菌、真菌、原生动物与病毒的代谢,延伸至环境微生物学、宿主与微生物相互作用、抗菌药物、微生物系统生物学、生物膜与微生物群。
- Research papers are not limited in size, while short communications carry soft limits of four to six figures or tables, four thousand words and a two hundred word abstract.研究论文不设篇幅上限,短篇通讯则有软性限制,即图表不超过四至六个、正文不超过四千字、摘要不超过两百字。
- The journal follows the Your Paper Your Way guideline, so authors may submit the main manuscript without any formatting requirements.本刊遵循(Your Paper Your Way)准则,作者投稿主文件时无需满足任何格式要求。
- As a gold open access title every article is permanently and freely available, and the full text is deposited in PubMed Central from Volume 1 onwards.作为金色开放获取期刊,所有论文均可永久免费获取,全文自第 1 卷起即存入(PubMed Central)。
- Recent papers centre on antimicrobial resistance, biofilms, microbiota and host-pathogen interplay, from carbapenem-resistant Klebsiella pneumoniae to phage infection dynamics in enteropathogenic Yersinia.近期论文以抗菌素耐药性、生物膜、微生物群与宿主和病原体相互作用为中心,从耐碳青霉烯肺炎克雷伯菌到肠道致病性耶尔森氏菌的噬菌体感染动力学。
History
- The journal began with Volume 1 in September 2020, published by Elsevier B.V. of Amsterdam as an online-only title under electronic ISSN 2666-5174.本刊第 1 卷于 2020 年 9 月问世,由阿姆斯特丹(Elsevier B.V.)出版,为纯在线刊物,电子 ISSN 为 2666-5174。
- A single volume appeared in each of the first three years, and two volumes a year have been published since 2023, with Volumes 10 and 11 running through 2026.创刊前三年每年一卷,2023 年起每年两卷,2026 年出版第 10 卷与第 11 卷。
- Articles are published online as soon as they pass editorial and peer review, so issues fill continuously rather than appearing on a fixed schedule.论文通过编辑与同行评审后即在线发表,各卷因此连续累积成卷,而非按固定档期出刊。
- The title was conceived as the primary research companion to the review journal Current Opinion in Microbiology, both sitting inside the Current Opinion and Research suite.本刊定位为综述刊(Current Opinion in Microbiology)的原创研究姊妹刊,二者同属(Current Opinion and Research)期刊群。
- The current article publishing charge is USD 3,580, excluding taxes, and the journal is listed in the Directory of Open Access Journals.现行文章出版费为 3,580 美元(不含税),本刊已被开放获取期刊目录(DOAJ)收录。
- The first Journal Impact Factor, 5.8, was recorded for 2024 and the 2025 value is 5.6, with a CiteScore of 8.2 and a first quartile placing in Microbiology.首个期刊影响因子 5.8 记于 2024 年,2025 年为 5.6,CiteScore 为 8.2,在微生物学类别居第一分区。
Editors
- The editor-in-chief is David M. Ojcius of the Department of Biomedical Sciences at the University of the Pacific in San Francisco, whose interests cover oral microbiology, microbiota and innate immunity.主编为旧金山(University of the Pacific)生物医学系的(David M. Ojcius),研究方向涵盖口腔微生物学、微生物群与固有免疫。
- Six associate editors serve under him, namely Celia Garcia in São Paulo, Michelle Kilcoyne in Galway, Lu Lu at Fudan University, Jennifer Ritchie at the University of Surrey, Sergio de los Santos Villalobos in Sonora and Jiwei Zhang at the University of Minnesota.其下有六位副编辑,分别是圣保罗的(Celia Garcia)、高威的(Michelle Kilcoyne)、复旦大学的(Lu Lu)、(University of Surrey)的(Jennifer Ritchie)、索诺拉的(Sergio de los Santos Villalobos)与(University of Minnesota)的(Jiwei Zhang)。
- The editorial board numbers forty-three editors and board members across eighteen countries and regions, led by the United States with fourteen and China with eight.编辑委员会由 43 位编辑与编委组成,来自 18 个国家与地区,其中美国 14 人、中国 8 人。
- Further members come from Brazil, Canada, France, Germany, Japan, Argentina, India, Iran, Ireland, Mexico, Saudi Arabia, South Africa, Switzerland, Taiwan, the United Kingdom and Uruguay.其余成员来自巴西、加拿大、法国、德国、日本、阿根廷、印度、伊朗、爱尔兰、墨西哥、沙特阿拉伯、南非、瑞士、中国台湾、英国与乌拉圭。
- Board figures include Gilbert Greub of the University of Lausanne on intracellular bacteria, Shibo Jiang of Fudan University on viral entry inhibitors and Shirley Luckhart of the University of Idaho on malaria.编委中包括(University of Lausanne)研究胞内菌的(Gilbert Greub)、复旦大学研究病毒入侵抑制剂的(Shibo Jiang)与(University of Idaho)研究疟疾的(Shirley Luckhart)。
- Review is single anonymized, editors first assess suitability and at least two reviewers then judge the manuscript, with the editorial office reporting one day to first decision and sixty-nine days from submission to acceptance.评审采用单匿名流程,编辑先评估稿件适配性,再由至少两位评审人把关,编辑部数据显示投稿至首次决定 1 天、投稿至接收 69 天。